Coating Place's Leadership Team Expansion to Drive Future Growth Initiatives

Coating Place Announces Strategic Leadership Appointments

As Coating Place marks its 50th year in operation, the company is poised for a new phase of growth. Celebrated for its pioneering work in Wurster-based fluid bed technology, Coating Place has established itself as a leader in controlled release and taste masking applications within the pharmaceutical sector.

In response to recent investments from 1315 Capital, Coating Place has made significant leadership changes aimed at fortifying its growth strategies and improving service for its customers across various markets.

Key Leadership Appointments

Rob Schrepfer has joined Coating Place's Board of Directors. Currently serving as the President of North American Generics at McKesson, Schrepfer's extensive expertise spans across generics, over-the-counter products, and biosimilars. His strategic insights into shifting customer demands within the pharmaceutical landscape will be invaluable as Coating Place looks to expand its market footprint.

Ajay Damani has assumed the role of President at Coating Place, reporting directly to CEO Tim Breunig. Damani brings a wealth of experience in the contract development and manufacturing organization (CDMO) sector, with a background that encompasses leadership positions in pharmaceutical, nutraceutical, and animal health markets. He is renowned for his ability to cultivate strong client relationships, drive innovation, and ensure consistent operational and commercial success.

These appointments reflect Coating Place's commitment to enhancing its capabilities and maintaining its position as a market leader. With the support of experienced leaders like Schrepfer and Damani, the company is well-positioned to respond to evolving customer needs and capitalizing on new market opportunities.

About Coating Place

Coating Place operates as a leading CDMO with a focus on Wurster fluid bed microencapsulation technology, which serves multiple industry segments. The company's diverse capabilities include formulation and analytical development, technology transfer, process scale-up, and comprehensive commercial manufacturing. With over 350,000 square feet of operating space across two facilities, Coating Place adheres to stringent GMP quality standards, holds FDA and Health Canada registration, and maintains DEA licensing.

As Coating Place celebrates this momentous milestone, the company is not just reflecting on its rich history; it is looking forward. The new leadership team is expected to play a crucial role in steering Coating Place toward a promising future filled with growth, innovation, and excellence in service for its clients.

For those seeking further information on Coating Place's services and its journey towards innovation and leadership in the pharmaceutical domain, additional resources are available at Coating Place's official website.

As the company embraces these pivotal changes, the industry watches closely to see how its new leadership will shape the next chapter in Coating Place's legacy.